FDA Launches Lasik Study, Sends Warning Letters

The U.S. Food and Drug Administration (FDA), National Eye Institute and U.S. Department of Defense will conduct a joint study looking at a potential link between Lasik and an increase in adverse event reporting.

This news follows the issuance of warning letters to 17 LASIK ambulatory surgical centers after inspections showed inadequate adverse event reporting systems at all the centers, according to the FDA.

The agency did not say where the centers are located.